News und Analysen
DMC Global Q2 Earnings Call Highlights
Key Points
- Interested in DMC Global? Here are five stocks we like better.
- DMC Global’s second-quarter sales reached $157 million, at the high end of guidance, while adjusted EBITDA of $10.7
Align Technology Q2 Earnings Call Highlights
Key Points
- Interested in Align Technology, Inc.? Here are five stocks we like better.
- Record Q2 revenue reached $1.06 billion, up 4.3% year over year, driven by an 8.2% increase in clear
CTO Realty Growth Q2 Earnings Call Highlights
Key Points
- Interested in CTO Realty Growth, Inc.? Here are five stocks we like better.
- CTO Realty Growth reported strong second-quarter results, with Core FFO rising to $18.4 million, or $0.53
Crane Q2 Earnings Call Highlights
Key Points
- Interested in Crane? Here are five stocks we like better.
- Record Q2 performance: Crane reported 26% sales growth, 37% adjusted operating-profit growth and a record 21.3% adjusted
Ardmore Shipping Q2 Earnings Call Highlights
Key Points
- Interested in Ardmore Shipping Corporation? Here are five stocks we like better.
- Strong quarterly performance: Ardmore Shipping reported $48.3 million in adjusted earnings, or $1.18
Acadia Realty Trust Q2 Earnings Call Highlights
Key Points
- Interested in Acadia Realty Trust? Here are five stocks we like better.
- Acadia reported strong second-quarter results, with FFO of $0.31 per share, 11% year-over-year earnings growth
The Ensign Group Q2 Earnings Call Highlights
Key Points
- Interested in The Ensign Group, Inc.? Here are five stocks we like better.
- Ensign raised its 2026 outlook after strong second-quarter results, with adjusted EPS up 20.8% to $1.92
D-Wave Quantum Aktie: AT&T beschleunigt Netzwerkoptimierung 240-fach
Ein Wechsel an die Nasdaq soll normalerweise Aufbruchsstimmung erzeugen. Bei D-Wave Quantum passiert genau…
Der Beitrag D-Wave Quantum Aktie: AT&T beschleunigt Netzwerkoptimierung 240-fach erschien
Strategic Education Q2 Earnings Call Highlights
Key Points
- Interested in Strategic Education Inc.? Here are five stocks we like better.
- Second-quarter performance improved: Revenue rose 3% to $330 million, operating income increased 9% to
Slide Insurance Q2 Earnings Call Highlights
Key Points
- Interested in Slide Insurance Holdings, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Net income rose 92.4% year over year to $134.9 million, while gross written
Option Care Health Q2 Earnings Call Highlights
Key Points
- Interested in Option Care Health, Inc.? Here are five stocks we like better.
- Q2 results exceeded expectations: Revenue rose 7% sequentially to $1.4 billion, while adjusted EBITDA
GE HealthCare Technologies Q2 Earnings Call Highlights
Key Points
- Interested in GE HealthCare Technologies Inc.? Here are five stocks we like better.
- GE HealthCare delivered solid underlying demand in Q2: Orders rose 11% year over year, backlog
Fortrea Q2 Earnings Call Highlights
Key Points
- Interested in Fortrea Holdings Inc.? Here are five stocks we like better.
- Fortrea raised its 2026 outlook after reporting second-quarter revenue of $678.2 million and adjusted EBITDA
Expand Energy Q2 Earnings Call Highlights
Key Points
- Interested in Expand Energy Corporation? Here are five stocks we like better.
- Capital allocation: Expand Energy reduced gross debt by $1.3 billion and repurchased $850 million of
Capital Clean Energy Carriers Q2 Earnings Call Highlights
Key Points
- Interested in Capital Clean Energy Carriers Corp.? Here are five stocks we like better.
- Revenue increased to $104.9 million in Q2 from $96.7 million a year earlier, while net income
EQS-HV: Bastei Lübbe AG: Bekanntmachung der Einberufung zur Hauptversammlung am 09.09.2026 in https://bastei-luebbe.hce-consult.com/ mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
EQS-HV: Bastei Lübbe AG: Bekanntmachung der Einberufung zur Hauptversammlung am 09.09.2026 in https://bastei-luebbe.hce-consult.com/ mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
Reynolds Consumer Products Q2 Earnings Call Highlights
Key Points
- Interested in Reynolds Consumer Products Inc.? Here are five stocks we like better.
- Second-quarter performance improved: Adjusted EPS rose 7% to $0.42, while first-half revenue
Conduit H1 Earnings Call Highlights
Key Points
- Interested in Conduit Holdings Limited? Here are five stocks we like better.
- Conduit returned to profitability in H1 2026, reporting $80.3 million of comprehensive income versus a
Insiders Sell, Institutions Buy: The AI Trade Is Getting More Interesting
Key Points
- Interested in Palo Alto Networks, Inc.? Here are five stocks we like better.
- Despite insider selling amid summer 2026 tech volatility, institutional investors are aggressively
EQS-News: Halbjahresabschluss der Allerthal-Werke AG zum 30. Juni 2026
EQS-News: Halbjahresabschluss der Allerthal-Werke AG zum 30. Juni 2026
abrdn H1 Earnings Call Highlights
abrdn (LON:ABDN) reported higher first-half profit and capital generation, supported by growth at its Interactive Investor platform, cost discipline and improved investment performance, while
Befesa Q2 Earnings Call Highlights
Key Points
- Interested in Befesa S.A.? Here are five stocks we like better.
- First-half performance improved: Adjusted EBITDA rose 11% to €124 million, supported by higher steel-dust recycling
EQS-News: Befesa erzielt starkes 2. Quartal 2026: Bereinigtes EBITDA steigt um 17% auf 66 Mio. €; Ausblick für das Gesamtjahr bekräftigt
EQS-News: Befesa erzielt starkes 2. Quartal 2026: Bereinigtes EBITDA steigt um 17% auf 66 Mio. €; Ausblick für das Gesamtjahr bekräftigt
Basilea erhält im Rahmen ihrer BARDA-Vereinbarung USD 30 Mio. für die Phase-3-Entwicklung des neuen Antipilzmittels Fosmanogepix
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 29. Juli 2026
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel
Basilea erhält im Rahmen ihrer BARDA-Vereinbarung USD 30 Mio. für die Phase-3-Entwicklung des neuen Antipilzmittels Fosmanogepix
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 29. Juli 2026
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel